Pharma

Your Article Summary

See Latest Articles

Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin (Human Growth Hormone)
Teva Pharmaceutical Industries, 07/01/09

Teva Pharmaceutical Industries Ltd. and its partner, Antares Pharma, Inc. announced the approval of a Supplemental New Drug Application, which added "needle-free injection" to its Tev-Tropin brand human growth hormone drug label. Teva will market the Antares needle-free device as the Tev-Tropin Tjet Injector system.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

 See all of Drug/Product Approvals